J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 1, 2006

Papers In Press, published online ahead of print December 6, 2005
J. Lipid Res., doi:10.1194/jlr.M500500-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M500500-JLR200v1
47/3/643    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maslowska, M.
Right arrow Articles by Cianflone, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maslowska, M.
Right arrow Articles by Cianflone, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on November 14, 2005
Accepted on December 5, 2005

Targeting the signaling pathway of acylation stimulating protein

Magdalena Maslowska, Helen Legakis, Farzad Assadi, and Katherine Cianflone

Medicine, Anatomie & Physiologie, Centre de Recherche Hôpital Laval, Québec, Québec G1V 4G5

Corresponding Author: Katherine.Cianflone{at}crhl.ulaval.ca

Acylation Stimulating Protein (ASP, C3adesArg) stimulates triglyceride synthesis (TGS) and glucose transport in preadipocytes and adipocytes. Recently, we have demonstrated that C5L2, a G protein coupled receptor, is functionally responsible for mediating ASP responses. However, little is known of the intracellular signalling pathway involved. In the present study, ASP signalling is compared to insulin-mediated stimulation of TGS in 3T3-L1 cells. ASP stimulation is not Gas or Gai mediated (neither pertussis toxin nor cholera toxin sensitive), suggesting that Gaq is a likely candidate. Phospholipase C (PLC) is required since Ca2+ chelator BAPTA-AM and PLC inhibitor U73122 decreased ASP stimulation of TGS by 93.1% (p<0.0.001) and 86.1% (p<0.004), respectively. Both wortmannin and LY294002 effectively blocked ASP effect by 69% (p<0.001) and 116.1% (p<0.003), respectively, supporting a role for PI3 kinase (PI3K). ASP treatment led to a rapid but transient 3.5 fold increase in Akt phosphorylation (maximal at 5 minutes, basal by 45 minutes) which was blocked by Akt inhibition, resembling treatment by insulin. Downstream of PI3K, the mTOR pathway is required for insulin but not ASP action. By contrast, both ASP and insulin activate the MAPK/ERK1/2 pathway with rapid (10 minutes) and pronounced (30 fold) increases in ERK1/2 phosphorylation. These effects were partially blocked by PD98059, a MAPK inhibitor (64.7% and 65.9% inhibition, respectively, p<0.001). Using anti-cPLA2-Ser505 (phosphorylation site of MAPK/ERK1/2), time-dependent (maximal at 30 minutes) and transient cPLA2 phosphorylation was demonstrated by Western. Thus ASP signaling involves sequential activation of PI3K and PLC with downstream activation of PKC, Akt, MAPK/ERK1/2 and cPLA2, all of which leads to an effective and prolonged stimulation of TG synthesis.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.